1H22 Financial Performance

Revenue and profit breakdown (by business segment) Revenue breakdown 1H2022 % of revenue ■Medical device 50.9% ■ Orthopedic ■Interventional 15.6% 11.3% ■Pharma packaging 15.1% Blood management 7.0% Profit breakdown 1H2022 ■ Medical device % of profit1 35.4% ■ Orthopedic 26.6% ■Interventional 5.3% Pharma packaging 26.9% Blood management 5.8% Revenue by product category (RMBmm) Profit by product category (RMBmm) 1H2022 1H2021 YoY growth (%) 1H2022 1H2021 YoY growth (%) Medical device product 3,553 2,985 19.0% 595 509 16.9% Orthopedic products 1,091 1,084 0.6% 447 432 3.4% Interventional products 786 753 4.4% 89 74 21.0% Pharma packaging products 1,056 958 10.3% 452 356 26.8% Blood management 489 450 8.8% 97 92 5.0% Total 6,975 6,230 12.0% 1,7102 1,4892 14.9% WEGO威高 Note: The calculation of profit breakdown does not include other segment profits of RMB30.6mm; 2 The total includes other segment profits of RMB30.6mm (1H2022) and RMB25.4mm (1H2021), which are not listed separately; Figures are only for the purpose of reflecting the trend at the operational level of the Company. The actual 10 figures are subject to performance reports

View entire presentation